WHO ICTRP trial
Efficacy and safety of pregabalin for the treatment of neuropathic pain in…
JPRN-UMIN000023117 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000023117 |
|---|---|
| Public title | Efficacy and safety of pregabalin for the treatment of neuropathic pain in patients undergoing hemodialysis |
| Scientific title | Efficacy and safety of pregabalin for the treatment of neuropathic pain in patients undergoing hemodialysis - Efficacy and safety of pregabalin in patients undergoing hemodialysis |
| Primary sponsor | Nihon University School of Medicine Divisions of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | neuropathic pain |
| Interventions | An initial dose of pregabalin at 25 mg; this was then increased up to a maximum of 150 mg. |
| Registration date | Nov 7, 2016 |
| Target size | 30 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: